ClinicalTrials HQ

PREVENT ALL ALS Study

PREVENT ALL ALS Study

Recruiting · NCT06581861 · Registry updated 2026-08-24
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
PREVENT ALL ALS StudyNutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorderRecruitingNot stated2026-08-24NCT06581861

4 results · Page 1 of 1

32 results · Page 1 of 2

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Barrow Neurological InstitutePhoenixUnited States50
CHALS-CCT, University of Puerto Rico, Medical Sciences CampusSan JuanPuerto Rico2
Columbia UniversityNew YorkUnited States154
Dartmouth Hitchcock Medical CenterLebanonUnited States79
Duke UniversityDurhamUnited States91
Georgetown UniversityWashington D.C.United States1
Henry Ford HealthDetroitUnited States75
Hospital for Special CareNew BritainUnited States3
Indiana UniversityIndianapolisUnited States160
John Hopkins UniversityBaltimoreUnited States4
Massachusetts General BrighamBostonUnited States2
Mayo ClinicJacksonvilleUnited States122
Nih/NindsBethesdaUnited States1
Northwestern UniversityChicagoUnited States727
Ohio State UniversityColumbusUnited States19
Penn State HealthHersheyUnited States15
Providence ALS CenterPortlandUnited States3
Saint Alphonsus Regional Medical CenterBoiseUnited States3
Temple UniversityPhiladelphiaUnited States50
Texas NeurologyDallasUnited States9
University of Alabama BirminghamBirminghamUnited States20
University of California IrvineOrangeUnited States49
University of California San DiegoLa JollaUnited States39
University of California, San FranciscoSan FranciscoUnited States294
University of Colorado Anschutz Medical CampusAuroraUnited States142